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1. Introduct ion 
The polyanion heparin, by virtue of its charge 
properties, is able to compete with nucleic acids in 
many protein-nucleic a id interactions. Thus heparin 
inhibits both ribonucleases [1-3] and initiation by 
bacterial [3,4] or eucaryotic DNA-dependent RNA 
polymerases. The presence of ribonuclease activity in 
chromatin preparations [3,5] has led to the suggestion 
that heparin be used to abolish this when studying 
RNA synthesis from such templates in vitro [3]. How- 
ever, the present manuscript indicates that heparin 
also causes gross structural modifications to the chro- 
matin template. 
2. Materials and methods  
[35 S] heparin (19.4 mCi/g) was purchased from the 
Radiochemical Centre, Amersham (Bucks, UK). Un- 
labelled heparin (Pularin Grade) was purchased from 
Evans Medical Co. (Speke, UK). All other chemicals 
were from sources previously given [5,6]. Unsheared 
chromatin was prepared as detailed previously [5,6] 
and was used immediately at a concentration f
5-600/ag DNA per ml. 0.25 ml assays for chromatin 
endogenous RNA polymerase activity were set up, in- 
cubated and processed as described previously [5,6]. 
Any modifications to this standard procedure are de- 
tailed in the legend to the figures. [3H] UTP was 
present at a specific radioactivity of 324 counts/min-~ / 
pmoles-~ in all assays except hose shown in figs. 1 a 
and 2 where the specific radioactivities were 130 and 
1625/min- 1 /pmoles- 1 respectively. Chromatin was 
present at 25-30 ~tg DNA per assay. Heparin or 
(NH4)zSO4 were added to certain assays during the 
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Fi& 1. The effect of increasing salt and heparin concentrations 
on chromatin endogenous RNA polymerase activity. A) En- 
dogenous chromatin RNA polymerase activity was assayed 
at increasing concentrations of ammonium sulphate as 
described in Materials and Methods with no further additions, 
(o o) with 120 ug/ml heparin added at each ionic 
strength (4 ............. 4) and with 250 ttg/ml rifampicin AF/0-13 
added at each ionic strength (a . . . . .  =). B) Endogenous 
chtomatin RNA polymerase activity was assayed at 0.13 M 
ammonium sulphate in the presence of increasing concen- 
trations of heparin. 
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Fig. 2. The effect of ionic strength and heparin on the size 
range of RNA products ynthesised by the endogenous chto- 
matin RNA polymerase. Assays were carried out at A) 0.13 M 
ammonium sulphate, B) 0.25 M ammonium sulphate and C) 
0.40 M ammonium sulphate in the absence of added heparin 
(o o) with 200 ~g,/ml heparin, (= m) or 1000/~g/ 
ml heparin (L z~). RNA products were analysed on 
formamide gradients as described in Materials and Methods. 
Arrow heads mark the position of 28 S, 18 S and 5 S HeLa 
[all] rRNA run under the same conditions. 
incubation but the additional volume was limited to 
20 #1 (see figs. 3 and 4). Assays for the experiment 
shown in fig. 4B also contained 10 units of form B 
rat liver RNA polymerase, prepared according to the 
method of Butterworth et al. [7i. 
Size ranges of in vitro synthesised RNA products 
(fig. 2) were estimated by a method escribed in de- 
tail elsewhere [5]. The assay mixtures, after incuba- 
tion, were layered over 12 ml 2-10% linear sucrose 
gradients in an 85% formamide medium. These gra- 
dients were centrifuged for 18 hr at 284 000g and 
25°C. Gradient fractions were precipitated in the 
presence of 500/~g per fraction of carrier bovine 
serum albumin. 
Possible binding of heparin to chromatin proteins 
was examined by comparing three samples respectively 
containing chromatin (800/ag DNA and 2000/.tg 
protein per ml), [as S] heparin (5 X 10 s counts/min- 1 / 
mg -1 and 1 mg/ml) and a mixture of these compo- 
nents, all in the absence of (NH4)2 SO4. Each of these 
samples (total vol. 4.0 ml) was layered over a 60 ml 
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Fig. 3. The effect of addition of heparin or high salt concen- 
trations before or after the onset of RNA synthesis as cataly- 
sed by the endogenous chromatin RNA polymerase oradded 
from B RNA polymerase. A) Assays for chromatin endoge- 
nous RNA polymerase were begun at 37°C in the presence of 
0.13 M ammonium sulphate. At the time points hown, he- 
parin was added to 1 mg/ml (o o) or ammonium sulp- 
hate to a final concentration f 0.40 M (~ ~). The con- 
trol with no additions is also shown (. . . . .  ). Time zero 
indicates addition immediately prior to incubation at37°C. 
B) The template activity of chromatin was assayed at 0.13 M 
ammonium sulphate in the presence of 10 'units' purified 
form B RNA polymerase with the addition of hepatin to 
1 mg/ml at the times shown. Corresponding endogenous RNA 
polymerase activities (fi~ 3A) have been deducted from all 
points o that the values hown represent only net added en- 
zyme activity. (. . . . .  ) control level of net added enzyme 
activity with no additions; (= m) with heparin (to 
1 mg/ml) added at the times shown. All incubations were 
continued up to a total of 30 min at 37°C. 
two-phase gradient from 5-60% sucrose in 10 mM 
Tris-HC 1, pH 8.0 (the gradient profile is given in 
fig. 5). The gradients were centrifuged for 4 days at 
100 000 g and 4°C, prior to fractionation i to 42 1.5 
ml fractions. The absorbance at260 nm of the gra- 
dient material was continuously monitored uring 
fractionation, and 100/al samples were taken from 
each fraction of the labelled gradients and were mixed 
with 2 ml of ethanol and 10 ml butyl PBD/toluene 
scintillant [6] for counting. Selected, pooled frac- 
tions were assayed for protein content by the method 
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Fig. 4. Time course of chromatin endogenous RNA poly- 
merase activity under various conditions. Normal assays were 
carried out as described in Materials and Methods at 0.13 M 
ammonium sulphate (,. =) 0.4 M ammonium sulphate 
(A A) at 0.13 M ammonium sulphate in the presence of 
1 mg]ml heparin from the outset (+ e) at 0.13 M ammo- 
nium sulphate but adding heparin to 1 mg/ml after 20 min 
(o . . . . .  o) and at 0.13 M ammonium sulphate but adding 
ammonium sulphate to 0.40 M after 20 min (zx . . . . .  zx). 
of Lowry et al. [8] and for DNA by the diphenyla- 
mine method [9]. 
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Fig. 5. The complexing of [3sS] heparin with chromatin asso- 
ciated proteins. Cttromatin was treated with [ a s S] heparin and 
sedimented inbiphasic 5-60% sucrose gradients as described 
in Methods. Control gradients containing [ 3 s S ] heparin and 
chromatin alone were run in parallel (A . . . . .  A) asS radio- 
activity per 100 #1 from each 1.5 ml fraction of the gradient 
loaded with ehromatin-hepariri mixture; (o o) as S 
radioactivity per 100 pl from each 1.5 ml fraction of gradient 
loaded with [as S] heparin alone; (. . . . .  ) absorbanee 
260 nm of gradient loaded with chromatin-heparin mixture; 
( ) absorbance 260 nm of gradient loaded with chroma- 
tin alone; ( ............... ) profile of sucrose density gradient. 
The inset to this figure shows the protein content of fractions 
from the gradient loaded with chromatin-heparin mixture 
(z~ . . . . .  z~); protein content of fractions from gradient 
loaded with chromatin alone (o o); the DNA content 
of fractions from the gradient loaded with the chromatin- 
heparin mixture (zx .............. .~); the DNA content from 
gradient loaded with chromatin alone (o .............. .o). 
3. Results and discussion 
A general parallelism between the effects on chro- 
matin of high salt and heparin is apparent from figs. 
1 -3  and 4. Both agents are known to remove pro- 
tein from chromatin [3,6] and it has been established 
that the net contribution by heparin to protein release 
decreases as the salt concentration is raised (see ref. 
[3] table 3, and from our own observations). Two 
primary effects m.ay be distinguished: a massive activa- 
tion of the endogenous RNA polymerase activity (figs. 
1,3 and 4) and an increase in average and maximal 
RNA product size (fig. 2). The activation might be due 
to ribonuclease inhibition by heparin [1-3] or salt 
[5], an increased rate of transcription, the removal 
of proteins which otherwise slow down or halt trans- 
cription (whether specifically or not), the release of 
'blocked' RNA polymerase molecules, or any combi- 
nation of these possibilities. Inhibition of ribonuclease 
and/or protein release from chromatin might also ex- 
plain the increase in product size induced by heparin 
or high salt concentrations. 
Chromatin prepared by this method contains endo- 
genous RNA polymerase activity which is totally sen- 
sitive to ot-amanitin (form B) and is only evident at 
high ionic strengths [6]. In the presence of low con- 
centrations of heparin (or even rifampicin AF/0-13), 
this activity becomes apparent at much lower ionic 
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strengths (fig. 1A). The effect of increasing concen- 
trations of heparin at low ionic strength is shown in 
fig. 1B. Fig. 2 demonstrates a marked two-phase 
effect of heparin on chrom.atin endogenous RNA 
synthesis. In the presence of 200/ag/ml heparin a
large stimulation is found at the lower ionic strengths, 
yet the product size is not increased. 1mg/ml heparin 
however increases the product size up to a maximum 
close to 28 S under all ionic conditions. From this 
data ribonuclease inhibition seems unlikely, a conclu- 
sion reinforced by the absence of small RNA frag- 
ments at the top of the gradients from assays at lower 
ionic strengths to which no heparin had been added. 
A significant exonucleolytic a tivity has indeed been 
found in chromatin [5], but this would have relatively 
little effect on product size and its inhibition could not 
possibly account for the massive stimulation of endo- 
genous activity with heparin at 0.13 M (NH4)2 SO4. 
It is unlikely that heparin or high ionic strength increase 
the rate of transcription; fig. 3B shows that most initia- 
tions by the added form B polymerase seem to occur 
within the first two minutes of the incubation (since 
heparin completely inhibits initiations when added at 
zero time) and addition of heparin at 5 or even 10 
min results in little net increase in activity over the 
control evel (no heparin added), implying that 
transcription rates must be similar both in the presence 
and absence of heparin. 
The possibility that RNA synthesis might termi- 
nate more rapidly at 0.13 M (NH4)2SO4 in the 
presence of heparin seems unlikely in view of the data 
given in fig. 4. A plateau of endogenous RNA syn- 
thetic activity is reached after 10-15 rain at low salt 
in the absence of heparin but not at high salt concen- 
trations or in the presence of heparin. Wholesale ter- 
mination involving the dissociation of the polymerase 
from the template cannot explain this plateau 
phenomenon since RNA synthesis can be reactivated 
by the addition of high salt or heparin at 20 min, 
although both agents abolish initiation by free RNA 
polymerase. It seems most likely that the effect of 
high salt or heparin concentration is to remove pro- 
teins from the template which otherwise restrict 
transcription. Lower heparin concentrations (up to 
200/ag/ml) might act via the release of 'blocked' 
polymerase molecules, there being no significant 
effect on product size. 
One major anomaly remains in that the stimula- 
tion of RNA synthetic activity is drastically reduced 
when heparin is added 2 min after the start of incu- 
bation rather than at time zero (fig. 3A). This drop is 
far less marked with high salt (where it might be ex- 
plicable in terms of true termination on a limited scale, 
consistent with the results in fig. 4). This alone should 
suggest caution in the interpretation f endogenous 
activities measured in the presence of high heparin 
concentrations abinitio. 
Because of its similar charge properties to DNA, it 
might be expected that heparin would bind to some of 
the proteins it displaces. This is confirmed by fig. 5 
which gives clear evidence of heparin-protein com- 
plex formation as judged by the sedimentation rate 
of the as S-labelled heparin in the presence and ab- 
sense of chromatin. Protein contents, determined over 
the crucial range of fractions, show that at least 20% 
of the total protein loaded onto the chromatin-hepa- 
rin gradient is associated with the leading edge of the 
heparin peak. This is over and above the protein 
levels found in parallel fractions from the gradient 
loaded with chromatin alone: no DNA is present in 
either case. Moreover, considerable dissociation of 
the chromatin DNA-protein complex in the presence 
of heparin is implied by the trailing out of the DNA as 
indicated by the 260 nm absorbance trace. 
4. Conclusions 
Although heparin may be a good ribonuclease inhi- 
bitor, its use in chromatin transcription studies must 
be approached with caution. Treatment with heparin 
results in gross modifications of the structure and tem- 
plate properties of chromatin. It must be concluded 
that heparin competes with DNA for chromatin-asso- 
ciated proteins, whether histones (which are known to 
be removed by high salt concentrations) or non-his- 
tone proteins has not been determined. 
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